Boston Scientific Corporation (BSX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Boston Scientific Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 48.91x | 70.89x | 52.73x | 94.83x | 58.10x | -621.10x |
| P/B Ratio | 5.82x | 6.04x | 4.36x | 3.77x | 3.63x | 3.32x |
| P/S Ratio | 7.03x | 7.85x | 5.90x | 5.22x | 5.08x | 5.14x |
| Profitability | ||||||
| Gross Margin | 69.0% | 61.3% | 62.0% | 60.8% | 62.8% | 56.2% |
| Operating Margin | 19.8% | 15.7% | 15.3% | 14.4% | 16.2% | 6.1% |
| Net Margin | 14.4% | 11.1% | 11.2% | 5.5% | 8.7% | -0.8% |
| EBITDA Margin | 18.6% | 23.5% | 24.2% | 21.6% | 21.2% | 15.2% |
| Liquidity | ||||||
| Current Ratio | 1.62x | 1.08x | 1.32x | 1.51x | 1.48x | 1.82x |
| Quick Ratio | 1.08x | 0.64x | 0.82x | 1.02x | 1.10x | 1.45x |
| Leverage | ||||||
| Debt/Equity | 0.51x | 0.51x | 0.49x | 0.53x | 0.57x | 0.62x |
YoY = year-over-year change. Source: FMP..